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Background & Aims 
In vitro, several data indicate that cell function can be regulated by the mechanical 
properties of cells and of the microenvironment. Cells measure these features by 
developing forces via their actomyosin cytoskeleton, and respond accordingly by 
transducing forces into biochemical signals that instruct cell behavior. Among these, the 
transcriptional coactivators YAP/TAZ recently emerged as key factors mediating multiple 
responses to actomyosin contractility. However, whether mechanical cues regulate adult 
liver tissue homeostasis, and whether this occurs through YAP/TAZ, remains largely 
unaddressed. 
Methods & Results 
Here we show that the F-actin capping protein CAPZ is a critical negative regulator of 
actomyosin contractility and mechanotransduction. Capzb inactivation alters stress fiber 
and focal adhesion dynamics leading to enhanced myosin activity, increased cellular 
traction forces, and increased liver stiffness. In vitro, this rescues YAP from inhibition by a 
small geometry; in vivo, inactivation of Capzb in the adult mouse liver induces YAP 
activation in parallel to the Hippo pathway, causing extensive hepatocyte proliferation and 
leading to striking organ overgrowth. Moreover, Capzb is required for the maintenance of 
the differentiated hepatocyte state, for metabolic zonation, and for gluconeogenesis. In 
keeping with changes in tissue mechanics, inhibition of the contractility regulator ROCK, or 
deletion of the Yap1 mechanotransducer, reverse the phenotypes emerging in Capzb-null 
livers. 
Conclusions 
These results indicate a previously unrecognized role for CAPZ in tuning the mechanical 
properties of cells and tissues, which is required in hepatocytes for the maintenance of the 
differentiated hepatocyte state and to regulate organ size. More in general, it indicates for 
the first time a physiological role of mechanotransduction in maintaining organ 






The mechanical properties of cells and tissues (i.e. whether they are soft or stiff) are 
thought to be important regulators of cell behavior. A recent advancement in our 
understanding of these phenomena has been the identification of YAP and TAZ as key 
factors mediating the biological responses of cells to mechanical signals in vitro. However, 
whether the mechanical properties of cells and/or the mechanical regulation of YAP/TAZ 
are relevant for mammalian tissue physiology remains unknown. Here we challenge this 
issue by genetic inactivation of CAPZ, a protein that regulates the cytoskeleton, i.e. the 
cells’ scaffold by which they sense mechanical cues. We found that inactivation of CAPZ 
alters cells’ and liver tissue’s mechanical properties, leading to YAP hyperactivation. In 
turn, this profoundly alters liver physiology, causing organ overgrowth, defects in liver cell 
differentiation and metabolism. These results reveal a previously uncharacterized role for 






Cell behavior is powerfully regulated by the mechanical properties of the 
microenvironment. Seminal studies indicated for example that ECM stiffness and the 
resulting cell geometry can drive the choice between proliferation, cell death or 
differentiation, often dominating over soluble cues and oncogenes[1-7]. The current model 
to explain these observations is that cells probe the physical properties of the 
microenvironment by exerting contractile forces on adhesion complexes generated by their 
actomyosin cytoskeleton [8-12]. In turn, actomyosin contractility regulates intracellular 
signaling pathways to regulate cell behavior. 
Several biochemical pathways respond to mechanical cues. Among them, YAP 
(Yes-associated protein 1) and TAZ (Transcriptional coactivator with PDZ-binding motif or 
WWTR1) are required mediators of multiple biological responses dictated in vitro by 
mechanical cues and actomyosin contractility[13-15]. YAP/TAZ function as transcriptional 
coactivators together with the TEAD family of transcription factors, and their activity is 
regulated by upstream inputs including the Hippo cascade, centered on the LATS1/2 
kinases[16,17]. In vivo, the function of YAP and of YAP-regulatory inputs has been studied 
with great detail in the liver tissue, where YAP activation leads to hallmark phenotypes[18-
29]. 
Despite the increasing array of techniques to measure cell’s and tissue’s 
mechanical properties[30], a question that remains largely unanswered is whether 
mechanotransduction and the control of F-actin dynamics is really at work to control adult 
tissue and organ homeostasis, and whether it does so through YAP or other pathways. 
Available functional data suggest a role for CAPZ as negative regulator of YAP activity, 
and as one factor capable of regulating the response of mammary epithelial cells to ECM 
stiffness in vitro[32,41,42]. Yet, how regulation of actin assembly dynamics at the filament 
barbed end by CAPZ[31] is sufficient to trigger those phenotypes remains unknown. By 
genetic inactivation in mice we here found an unexpected role for CAPZ in regulating cell 
contractility and tissue stiffness. This is relevant in adult hepatocytes to restrain YAP 
activity, such that CAPZ inactivation in the liver leads to organ overgrowth, hepatocyte 
dedifferentiation and alteration of physiological liver metabolic functions. These 
phenotypes can be rescued by inhibition of cell contractility and by inactivation of YAP, 
thus unveiling a role for mechanotransduction in regulating organ size and tissue 







Mice and treatments 
Capzbtm1a(EUCOMM)Wtsi EM:04820 (EUCOMM/EMMA repository) mice were maintained into 
the C57BL/6N strain. Yap1fl/fl and ROSA26-LSL-LacZ mice were kindly provided by Dr. 
Pan. Mice were kept in standard cages with a limit of 5 mice per cage, with ad libitum 
feeding at an average temperature of 19-24°C. Gender was random. Animal experiments 
were performed according to our institutional guidelines as approved by the University 
Animal Welfare Commission (OPBA) and authorized by the Ministry of Health (945/2015-
PR and 54/2015-PR). Reporting was according to the ARRIVE guidelines. 
 The neo and lacZ cassettes in the Targeted allele (Supplementary Fig. 1A) were 
removed by crossing with the CMV-FLP deleter line, generating Capzbfl/fl mice. 
Subsequent crossing were made to obtain Albumin–CRE-ERT2; Capzbfl/fl; ROSA26-LSL-
lacZ mice. Mice received 5 consecutive daily i.p. injections of tamoxifen starting at 4-6 
weeks of age and analyzed after one month. Control mice were mice of the same 
genotype but injected with corn oil only, or age-matched littermates without the CRE 
transgene and induced with tamoxifen. Crossing with the CAGG-CRE deleter was used to 
obtain Capzb+/- mice, which were born at the expected mendelian ratio. Crossing of 
Capzb+/- mice did not produce any viable Capzb-/- offspring (not shown, but significant by 
chi-squared test). YAP LKO mice were Albumin–CRE-ERT2; Yap1fl/fl; Wwtr1fl/fl; 
ROSA26-LSL-lacZ. 
For genotyping, mice were anesthetized using isoflurane to surgically remove the 
tail tip. Genomic DNA was extracted with NaOH at 95°C for 30 minutes, followed by Tris-
base pH=8 neutralization. DNA was diluted in water and used for PCR with the following 
pairs of oligos: Capzb-floxed: CAP 71+84; Capzb-null: CAP 71+48; Yap1-floxed: P1+P2; 
Yap1-null: P1+P3. Primer sequences were CAP 71: AGCCCCTTGTCTGGTAAAAGA; 84: 
AGCAGAGTAATCAGCTCACCT; 48: CCCCGGAGCATATGAACTGA; YAP P1: 
CCATTTGTCCTCATCTCTTACTAAC; P2: GATTGGGCACTGTCAATTAATGGGCTT; P3: 
CAGTCTGTAACAACCAGTCAGGGATAC; CRE: CCTGGAAAATGCTTCTGTCCG, 






350mg/kg Acetaminophen (APAP, #A7085 Sigma-Aldrich) was injected i.p. in sterile 
1XPBS. Serum was collected 8 hours after APAP-injection, livers after 24 hours. Fasudil 
(LC-laboratories F-4660) was provided in drinking water at an estimated 250mg/kg for 2 
weeks, starting together with the first tamoxifen injection. 
Hydrodynamic tail vein (HTV) DNA injection 
50μg of PiggyBac (PB)-transposon plasmid DNA together with 10μg of hyperactive PB 
Transposase (hyPBase, Addgene 34879) were diluted in sterile Ringer’s solution in a 
volume corresponding to 10% of the body weight, and injected via the tail vein of 4/6-
week-old mice (18-22gr) in a maximum time of 8-10 seconds. PB-CAS9 and PB-RFP-
LATS1/2-sgRNA were as in Ref. [32]. 
Liver sampling 
Trans-cardiac perfusion (29-gauge needle) with cold 1XPBS (10-20ml) was performed on 
euthanized mice to reduce blood contaminants. The liver was placed in 1XPBS on ice, 
dissected and snap-frozen in liquid nitrogen for extraction of mRNA / proteins, or 
embedded in OCT and stored at -80°. 
Serum measurements 
Alanine aminotransferase (ALT) activity was measured in serum using ALT Activity Assay 
(MAK052 Sigma). Mice were anesthetized with tribromoethyl alcohol (T48402 Sigma) and 
2-methyl-2-butanol (240486 Sigma), and blood were collected from the retro-orbital sinus. 
Blood was clotted at RT for 1 hour and centrifuged for 10 minutes. The serum was stored 
at -80° for later analysis. Blood glucose levels were measured with CountourXT 
glucometer (Bayer). IPGTT assays were carried out by intraperitoneal injection of 2mg/g 
Glucose after overnight starvation. 
Antibodies, western blotting and stainings. 
CAPZB (SC-81804 for WB, AB6017 Merck for IF), YAP (SC-101199, IF vitro; 13584-1-AP 
Proteintech, IF in vivo), S19 pMLC (3675 CST, requires permeabilization in -20°C 
Acetone), CK19 (TROMAIII DSHB, requires OCT inclusion of non fixed tissue), A6 (A6 
BCM, DSHB), GS (610517 BD, better on tissues fixed with PFA prior to OCT inclusion), 
CYP8B1 (SC-101387), pH3 (9701 CST), CD45 (MCA1388 Serotec), HNF4a (SC-6556), 
HES1 (11988 CST, without tyramide amplification), β-gal (ab9361 Abcam), RFP (10367 





(SC-6216), Vinculin (SC-73614), a-Actinin (A7811 Sigma). Secondary isotype-specific 
anti-mouse labeled IgG were used to decrease background staining. 
For immunofluorescence on liver sections, OCT-embedded tissue was cut into 5-
8µm thick sections with a Leica CM1950 cryostat. Sections were dried at RT for 30 
minutes on a glass coverslip (VWR), and either stored dried at -80°C or directly processed 
by rehydration in 1XPBS followed by fixation in 4% PFA for 15 minutes. Permeabilization 
was performed in 1XPBS-Triton 1% for 20 minutes. Blocking was 10% goat serum in 
1PBS-Triton 0.5% for 1 hour at RT. CK19-positive area was quantified by measuring the 
proportion of CK19-positive pixels over the total number of pixels, by using binary 
thresholded pictures (ImageJ). For phalloidin staining, Alexa Fluor-conjugated phalloidin 
(Thermofisher) was incubated with secondary antibody in blocking buffer. For histological 
analysis, paraffin-embedded liver tissue was cut into 5μm sections and stained with 
hematoxylin-eosin for histologic examination or with Picrosirius Red to visualize fibrosis 
(commercial kits and protocols). For EdU labelling, mice were injected with 12.5mg/kg of 
EdU in sterile 1XPBS (A10044 Molecular Probes) 15 hours before tissue sampling. Cells 
were incubated for 1h with EdU prior to fixation. Liver slice or cells were fixed in PFA 4% 
and blocked/permeabilised for 30 minutes in 1xPBS 3% BSA + 0.2% Triton (1% Triton for 
liver slices). EdU reaction mix (100mM Tris pH 8.5, 4mM CuSO4, 625 nM Alexa Azide, 
100mM Ascorbic acid) was incubated for 30 minutes, and staining with other antibodies or 
DAPI was then performed as described above. TUNEL staining was performed according 
to the DeadEnd™ Fluorometric TUNEL System (Promega). Images were acquired with a 
Leica SP5 or with a ZEISS LSM700 confocal microscope equipped with CCD camera, 
using Leica LAS AF or ZEN 2 software, or with a standard Leica DM5000B microscope. 
Immunofluorescence on cells and western blotting was as in[33]. 
RNA extraction and gene expression studies 
Total liver RNA extractions were performed using Trizol (Thermo) extraction, starting from 
5-10mg of liver tissue. Contaminant DNA was removed by RNase free-DNase (Thermo). 
For cells, total RNA extraction was performed using RNeasy kit (Quiagen) and 
contaminant DNA was removed by RNase-Free DNase Set (Qiagen). RNA-sequencing 





performed using TruSeq Stranded mRNA Library Prep Kit (Illumina) according to the 
manufacturer’s protocol, and sequenced with an Illumina NextSeq 500 platform (75bp, SE, 
≥15*10^6 reads/sample). Raw reads were aligned using STAR (version 2.5.3a) [34] to 
build version mm10 of the mouse genome. Counts for UCSC annotated genes were 
calculated from the aligned reads using featureCounts function of the Rsubread R 
package[35] in R-3.3.1. Normalization and differential analysis were carried out using 
edgeR R package[36]. Raw counts were normalized to obtain Count per Million mapped 
reads (CPM) and Reads Per Kilobase per Million mapped reads (RPKM). Only genes with 
a CPM greater than 1 in at least 4 samples were retained for differential analysis. 
Retro-transcription was carried out with dT-primed M-MLV Reverse Trascriptase 
(Thermo). qPCR analyses were carried out with triplicates of each sample cDNA on 
QuantStudio 6 Flex Real-Time PCR System (Thermo) with a FastStart SYBR Green 
Master Mix (Roche). Expression levels were calculated relative to GAPDH based on the 
efficiency^-ΔCt method. qPCR primer sequences were GAPDH: 
ATCCTGCACCACCAACTGCT, GGGCCATCCACAGTCTTCTG; ANKRD1: 
CTGTGAGGCTGAACCGCTAT, TCTCCTTGAGGCTGTCGAAT; CYR61: 
GCTCAGTCAGAAGGCAGACC, GTTCTTGGGGACACAGAGGA; BICC1: 
CTCGCAGCCAACATATGTCC, GTTGGCTCTCCTCAGTTCCT; TAGLN2: 
AGCAGATCCTCATCCAGTGG, CCATCTGCTTGAAGGCCATC. 
Cell lines 
Primary mouse adult fibroblasts (MAFs), were obtained by standard procedures after 
enzymatic digestion of the tail-tip and plated in DMEM+20% FBS, 1% Gln, Pen/Strep. 
MAFs were kept in a low-oxygen (5%) incubator to prevent stress-induced senescence. 
Subsequent manipulations and experiments were performed in a standard incubator. Cells 
were routinely tested negative for mycoplasma contamination (ATCC Kit). Plasmid DNA 
(GFP-Actin, mCherry-Vinculin) was electroporated according to the manufacturer’s 
instructions. Viral infections (Adeno-empty UIowa-272 and Adeno-CRE UIowa-5) were 






Substrates were made of polyacrylamide (PAA), polymerized on standard 25mm glass 
coverslips. (3-Aminopropyl) trimethoxysilane (APTMS) was applied to the glass surface for 
3min, followed by washes with ddH2O, and treatment with 0.5% glutaraldehyde for 30min. 
A pre-mixed solution was made of 500μl 40% acrylamide, 65μl 100% hydroxy-acrylamide 
and 250μl 2% bis-acrylamide (Bis-AA, Fisher scientific), and diluted in PBS to obtain the 
desired stiffness. After 15min de-gassing, TEMED and APS were added to initiate the 
cross-linking, and 50μl of the solution immediately pipetted on the coverslips. A plasma-
cleaned coverslip made hydrophobic with RainX (Kraco Car Care International Ltd.) was 
lowered onto the drop to ensure even thickness; this was later covered with PBS and 
removed. The gels were washed in PBS and sterilized under UV light. Gels were treated 
with 100μg/ml poly-D-lysine (PDL) overnight, and then with Fibronectin for 1 hour to 
promote cell adhesion. All chemicals were from Sigma-Aldrich, unless otherwise stated. 
Micropatterned glass slides[13] were from Cytoo SA (PADO-1 custom mask, available to 
all users upon request). For each slide, 80.000 cells were plated in a 6-well plate dish 
containing a single slide, and non-adherent cells were washed with medium after 2 hr. 
Fluorescence Recovery After Photo-bleaching (FRAP) 
24 hours after transfection (mCherry-Vinculin or GFP-Actin), MAFs were re-seeded on 
glass-bottom dishes (Matek, Sigma-Aldrich) coated with 10µg/ml fibronectin, and imaged 
in Ringer’s phenol-red free medium upon complete spreading with a Confocal Spinning 
Disk microscope (Olympus) equipped with a 100x/1.35Sil silicone oil immersion objective, 
a iXon897 Ultra camera (ANDOR) and a FRAP module equipped with a 405nm laser. 
Environmental control was maintained with an OKOlab incubator. Circular Regions Of 
Interest (ROI) of 2µm diameter were photo-bleached at 50% intensity for Actin and 100% 
intensity for Vinculin, and post-bleaching images were followed with 15 to 20% laser 
intensity for 100 frames (1 frame every second for Actin, every 0.5 seconds for Vinculin). 
FRAP data were analyzed as reported[37] and curves fitted to a monoexponential 
recovery equation by the Graphpad Prism software:                   I= I0+Imax*[1-e-(k)*(t)] 
Where I is the relative intensity compared to the pre-bleaching value, k represents the 
association rate constant, and t is expressed in seconds. 





TIRF microscopy of MAFs was performed using a DMI6000B equipped with AM TIRF 
module (Leica). Images were acquired using either a PlanApoN 60× 1.45-NA or UApoN 
100× 1.49-NA TIRF oil-immersion objective, captured using a Ixon+ EMCCD camera 
(Andor). All images were acquired with the same camera settings and laser intensity for 
consistent image analysis. A custom macro, available upon request, was designed to 
quantify the number and size of focal adhesions per cell. Images containing a single cell 
were background-subtracted and a binary mask was created by applying non-linear filters. 
The mask was then applied on raw images to obtain particle sizes and area. Only particle 
sizes >200nm2 were considered in the analysis, as this avoided analysis of background 
particles. All images were acquired with the same settings and consistently analyzed by 
concatenating all images, while saturated images were discarded. 
Traction Force Microscopy (TFM) 
Preparation of Polyacrylamide (PAA) Substrates. PAA gels were prepared on imaging 
dishes (μ-Dish, Ibidi, Germany) as previously described[38]. Fluorescent nanoparticles 
(FluoSpheres carboxylate, 0.2 μm, crimson, Life Technologies, UK) were added to the 
PAA pre-mixes, which were then placed in an ultrasonic bath for 30s to separate the 
beads. After starting polymerisation, the imaging dish was inverted to ensure that beads 
settled close to the gel surface. 
Time Lapse Imaging for TFM. MAFs were seeded onto PAA gels with shear storage 
moduli G’ of 1 kPa (‘soft’) and 10 kPa (‘stiff’). After 24 hours, cells where imaged using an 
inverted microscope (Leica DMi8) at 37°C and 5% CO2, equipped with a digital sCMOS 
camera (ORCA-Flash4.0, Hamamatsu Photonics), an EL6000 illuminator (Leica, 
Germany), and a 63x oil objective (NA1.4, Leica, Germany). Images were acquired using 
Leica LAS X software. Fluorescence images of beads, and widefield images of cells were 
taken every 2 minutes. After image acquisition, culture media were exchanged with 
Trypsin-EDTA (Gibco) to detach cells from the gel. Reference images of fluorescent beads 
were taken 15 min after trypsinisation. Three independent traction force experiments were 
performed for each condition. 
Data Analysis for TFM. Traction stress maps were calculated for each frame using a 
TFM Software Package in ImageJ[39]. To minimize noise, regularisation parameters of 
0.01 and 0.00001 were chosen for cells on 1 kPa and 10 kPa PAA gels, respectively 





statistical analyses were done with a custom Python script. The distributions of the 
average stresses were compared using Mann-Whitney tests. 
Atomic Force Microscopy (AFM) 
All AFM experiments were performed in accordance with the UK Animals (Scientific 
Procedures) Act 1986. Mice were sacrificed via an approved schedule 1 method. Livers 
were immediately dissected and embedded in low melting point agarose (4% in PBS; 
Sigma Aldrich). A small block of agarose containing the sample was submerged in chilled 
PBS and cut into 500 μm thick sections using a vibratome (Leica). Sections were slowly 
heated to 37 °C in PBS for 30 min prior to AFM measurements. AFM measurements were 
carried out similarly as previously described[40]. Monodisperse polystyrene beads (radius 
r = 18.64 µm ± 0.17 µm, microParticles GmbH, Berlin, Germany) were glued to tipless 
silicon cantilevers (spring constants between 0.01 and 0.03 N/m; Arrow-TL1, NanoWorld, 
Neuchatel, Switzerland). The AFM was mounted on an x/y motorized stage of an inverted 
microscope (AxioObserver A1, Zeiss, Cambridge, UK). Cantilever position relative to the 
liver sections was monitored via a CCD camera (The Imaging Source, Bremen, Germany) 
placed on top of the AFM setup. Force-distance curves were taken with a set force of 
10nN with an approach speed of 10μm s-1. Apparent elastic moduli K were calculated 
using the Hertz model: F = 4/3 K r1/2 δ3/2 for an indentation depth δ = 2 µm, using a custom 
written automated algorithm based in Matlab (MathWorks, Natick, USA). Stiffness was 
measured in maps over defined sample areas, over which multiple force-distance curves 
were taken at 20 μm steps (each map containing 40-200 measurements, 2-3 maps per 
liver). The median measurement stiffness for each map was calculated, and statistical 
significance between maps was determined using a two-tailed Student’s t-test. 
Statistical analysis 
Data analyses were performed using GraphPad Prism software. Graphs indicate mean 
values and single values of all biological replicates (or mice), unless otherwise indicated. 
Data for each mouse derive from analysis of multiple (n≥6) tissue sections. To facilitate 
gene expression data visualization, the mean expression levels in WT mice was set equal 
to 1, and all other data (single values, means and errors) are relative to this. Significance 





Student’s t-tests (n≥4 samples); for RNA sequencing, we considered as significant only 
genes with P<0.05. 
Data availability 
Data that support the findings is available in the manuscript or upon reasonable request to 
the corresponding author. RNA seq data have been deposited in GEO database 







Derivation and validation of a Capzb floxed allele.  
To functionally dissect the role of mechanotransduction and F-actin dynamics in vivo, we 
chose to inactivate the F-actin capping protein CAPZ. CAPZ is a dimer whose alpha 
subunit is encoded by two loci in mammals (Capza1 and Capza2), while the beta subunit 
is encoded by only one gene (Capzb - Gene ID: 12345), facilitating genetic analysis. We 
thus recombined the Capzbtm1a(EUCOMM)Wtsi allele to obtain Capzb-floxed mice (see Methods 
and Supplementary Fig. 1A-B); the same allele was recently used in Ref. [41]. We 
validated this allele by monitoring efficient depletion of the endogenous CAPZB protein in 
primary adult Capzb-fl/fl fibroblasts recombined by adenoviral-CRE infection 
(Supplementary Fig. 1C). Moreover, adenoviral-CRE recombination of primary newborn 
Capzb-fl/fl cardiomyocytes led to a rapid disassembly of contractile actomyosin structures 
(Supplementary Fig. 1D), in line with the role of CAPZ in muscle sarcomeres[31]. We 
speculate this defect might underlie the lethality of Capzb-/- embryos (see methods). 
We also aimed at specifically validating the role of CAPZ in the context of 
mechanotransduction. For this we compared the biological response of WT (Capzbfl/fl + 
adeno-control) and CAPZ KO (Capzbfl/fl + adeno-Cre) primary adult fibroblasts (MAFs) to 
mechanical cues: WT MAFs respond to a small cell geometry, which is associated to 
decreased actomyosin contractility[42], by inactivating YAP/TAZ and by decreasing 
proliferation (Fig. 1A and B), in line with Ref. [13,14]; in contrast, CAPZ KO MAFs  retained 
nuclear YAP and kept proliferating, at least to a certain extent (Fig. 1A and B). As a 
control, CAPZ KO MAFs completely detached from the substratum maintain YAP nuclear 
exclusion (not shown). Thus, Capzb is required in MAFs for the inhibition of YAP in 
conditions of decreased contractility. 
 
Capzb limits actomyosin contractility in response to ECM mechanical cues 
We then sought to understand at what level does CAPZ act to regulate 
mechanotransduction. We analyzed F-actin and focal adhesions (FAs) in WT and CAPZ 
KO MAFs, as these are critically involved in cell mechanics. Phalloidin staining on fixed 
cells indicated thinner and denser bundles in CAPZ KO MAFs (Fig. 1C). FRAP 
(Fluorescence Recovery After Photobleaching) analysis of Actin dynamics in stress fibers 





previously associated to higher levels of Myosin-II activity[43,44]. Analysis of Vinculin 
dynamics in focal adhesions (FAs) indicated a slower recovery in CAPZ KO cells (Fig. 1E), 
and thus more stable Vinculin, a typical feature observed upon increased pulling forces or 
upon stiffening of the ECM[45-48]. This was associated with a higher number of Vinculin-
positive FAs, but of smaller size (Fig. 1F). During these analyses we noted a redistribution 
of FAs from predominantly peripheral to a more central position, perhaps reminiscent of 
the recently-described perinuclear FAs specifically associated to increased tension and 
YAP activity[49]; to quantify this phenotype we plated MAFs on cross-bow shaped 
fibronectin micropatterns and averaged the intensity of the staining over several stacked 
cells[50,51], confirming our observation (Fig. 1G). Furthermore, CAPZ KO MAFs display 
increased levels of active S19-phosphorylated myosin light chain (pMLC - Fig.1H), and 
increased cellular forces on stiff hydrogels (G’ = 10kPa), as measured by traction force 
microscopy (Fig. 1I). Finally, we extended these findings in the context of a soft ECM 
microenvironment, where CAPZ inactivation is relevant to regulate YAP/TAZ[52]: pMLC 
staining was almost undetectable in MAFs on soft hydrogels (G’ = 1kPa), but clearly visible 
in CAPZ KO MAFs (Fig. 1J). Moreover, CAPZ KO MAFs exerted significantly higher forces 
on their substratum also in this condition compared to control cells (Fig. 1K). Collectively, 
these data indicate that deletion of Capzb enables the development of higher cellular 
forces even in conditions of decreased extracellular resistance, unveiling a previously 
unsuspected role for CAPZ. Moreover, this validates Capzb inactivation as a meaningful 
tool to modulate F-actin dynamics and cell mechanics in vivo. 
 
Conditional inactivation of Capzb in hepatocytes activates the YAP 
mechanotransducer 
To probe a role of Capzb as regulator of tissue physiology we focused on the liver, 
because hepatocytes are inherently mechanosensitive[1,53] and because it is a model 
system for Hippo/YAP [54-56]. We thus obtained Albumin-CRE-ERT2; Capzb-fl/fl; 
ROSA26-LoxSTOPLox-lacZ mice (hereafter, CAPZ LKO) to delete Capzb in adult 
hepatocytes in a time-controlled manner, and enabling the lineage tracing of recombined 
cells by beta-galactosidase expression (Fig. 2A, Supplementary Fig. 2A and B). 
We initially sought to find evidence for activation of the YAP mechanotransducer in 
CAPZ LKOs. We monitored a series of established YAP target genes in the liver 





performed a more global analysis of gene expression and found that genes activated in 
CAPZ LKOs are remarkably overlapping with those activated in Hippo-mutants[26,28,57] 
and Yap-transgenics[18,20,58] (Fig. 2C). Prompted by these results, we directly monitored 
endogenous YAP localization by immunofluorescence, and found increased nuclear 
localization in Capzb-null hepatocytes (Fig. 2D and Supplementary Fig. 2H). Of note, 
mutant liver tissues also display an overall increase in YAP staining intensity (Fig. 2E). 
 
Control of liver organ size by inactivation of Capzb 
Phenotypically, inactivation of Capzb caused an evident hepatomegaly reaching on 
average 200% of the normal liver/body weight ratio (Fig. 2F). Hepatocytes appeared 
enlarged, similarly to what observed in Lats1/2 knockouts[26] (see Supplementary Fig. 
2A), and exhibited a stark increase in proliferation as measured by EdU incorporation (i.e. 
S-phase) and phospho-Histone3 (i.e. mitosis) staining (Fig. 2G and H and Supplementary 
Fig. 2C). This was accompanied by overexpression of several proliferation markers (Fig. 
2I), including known direct YAP targets[58,59], and of antiapoptotic genes (Supplementary 
Fig. 2D). As control, we excluded major alterations of cell-cell junctions (Supplementary 
Fig. 2E), previously observed by CAPZ inactivation in flies[60], fibrosis (see 
Supplementary Fig. 2A) and inflammation (Supplementary Fig. 2F and G). This indicated 
that CAPZ is required in adult hepatocytes to keep control over a key 
mechanotransduction pathway, and that it potently restrains hepatocyte proliferation. 
 
Capzb controls liver cell fate 
Activation of YAP in hepatocytes leads to expansion of atypical ductal cells (ADCs) / oval 
cells / biliary epithelial cells (BECs) that display bipotent progenitor identity[20,23]. 
Analysis of CAPZ LKO livers indicated a massive expansion of A6- and CK19-positive 
ADCs forming disorganized strands in the liver parenchyma, mainly distributed around the 
portal area (Fig. 3A), and this was accompanied by increased expression of 
cholangiocyte/progenitor markers[20,61] in CAPZ LKO livers (Fig. 3B). Appearance of 
ADCs upon YAP activation has been attributed to dedifferentiation of hepatocytes, with 
appearance of cells double-positive for CK19 and HNF4α (markers for the cholangiocyte 
and hepatocyte lineages, respectively) [20], which we also found in CAPZ LKO livers (Fig. 





dedifferentiation[20,62], we found the Notch pathway activated in CAPZ LKO livers (Fig. 
3D and E). To unequivocally trace ADCs to hepatocytes bearing Capzb deletion, we 
performed a double staining for beta-galactosidase (which labels recombined hepatocytes) 
and CK19, and found co-localization (Fig. 3F). Of note, this indicated dedifferentiation of 
hepatocytes also at a distance from the portal area. As an alternative approach, we 
expressed a Cre transgene in hepatocytes of Capzb-fl/fl mice by hydrodynamic tail vein 
(HTV) transposon DNA injection[63], which caused appearance of cells doubly positive for 
CK19 and beta-galactosidase (Fig. 3G). This indicates a cell-autonomous function of 
Capzb. More in general, these data indicate that Capzb inactivation is sufficient to 
reprogram adult hepatocyte fate. 
 
Capzb controls hepatocyte zonation and liver metabolism 
Metabolism in the liver parenchyma is zonated, with hepatocytes expressing different 
metabolic genes along the periportal to pericentral axis of the hepatic lobules in response 
to several signaling cues[64-66]. Recent evidence indicates that YAP activity contributes to 
zonation by inhibiting pericentral gene expression[28]. We thus checked for expression of 
established pericentral markers in CAPZ LKO livers, and found them strikingly reduced 
both at the mRNA level (Fig. 4A) and by immunostaining (Fig. 4B and C). Pericentral 
zonation is particularly evident if looking at the expression of cytochromes involved in 
xenobiotic metabolism[66,67]. Among these we focused our attention on Cyp1A2 and 
Cyp2E1, the main genetic determinants of acetaminophen (APAP) toxicity in the 
mouse[68], which we found strongly inhibited (see Fig. 4A). Reflecting decreased 
expression, we then found that CAPZ LKO were extremely resistant to APAP intoxication: 
at sub-lethal doses (350mg/Kg) sufficient to cause extensive cell death (as measured by 
TUNEL assay) and extensive hepatic damage (as measured by serum ALT) in WT mice, 
CAPZ LKO mice remained insensitive (Fig. 4D and E). 
Another recently reported function of YAP in the liver is the regulation of 
gluconeogenesis and blood glucose homeostasis[29]. Accordingly, we found decreased 
expression of key gluconeogenic genes in CAPZ LKO mice (Fig. 4F), and this was 
functionally linked to decreased steady-state blood glucose levels and improved glucose 
tolerance (Fig. 4G). Overall, these data indicate that Capzb is relevant to maintain the 






Capzb regulates liver homeostasis through YAP 
To obtain formal evidence that phenotypes observed upon Capzb inactivation are due to 
YAP activation, and not to other mechanoresponsive pathways, we deleted Yap1[22] in 
CAPZ LKOs (Albumin-CreERT2; Capzb-fl/fl; Yap1-fl/fl; ROSA26-LSL-lacZ mice, 
CAPZ+YAP LKO). As shown in Fig. 5A-E and Supplementary Fig. 3A, Yap1 inactivation 
partially rescued hepatomegaly and proliferation, while it almost completely rescued 
atypical ductal cell expansion, pericentral expression, and glucose tolerance. We 
speculate the partial rescue might depend on TAZ, which is functional in hepatocytes[69] 
and sufficient to induce hepatocyte proliferation (see Fig. 5G). This would also imply that 
the phenotypes described above require different thresholds of YAP/TAZ activity. Thus, 
the control of F-actin assembly dynamics is a physiologically-relevant input to keep control 
over YAP/TAZ activity in the liver. 
 
Capzb regulates YAP/TAZ in parallel to Hippo 
Some data suggest that mechanical regulation of YAP/TAZ involve YAP phosphorylation 
by LATS kinases; functional data however indicate that mechanical regulation of YAP/TAZ 
can occur in the absence of LATS1/2[15]. The effectiveness of Capzb inactivation in 
regulating YAP/TAZ in hepatocytes offered us the opportunity to test the genetic 
interaction with Lats1/2 in vivo. We thus expressed in the liver, by HTV transposon 
injection, the CAS9 enzyme and guide-RNAs targeting Lats1 and Lats2[32], to inactivate 
Lats1/2 without inducing liver failure caused by whole-organ knockout[26,70]. CRISPR 
inactivation of Lats1/2 induced multiple YAP-dependent phenotypes (Supplementary Fig. 
3B-D), indicating efficient recombination of both genes[26,32,71,72]. We then found that 
the combination of Capzb and Lats1/2 inactivation induced a higher number of proliferating 
cells compared to Lats1/2 inactivation alone (Fig. 5F and Supplementary Fig. 3E), ruling 
out the possibility that CAPZ works only through LATS1/2 to regulate YAP. We also 
injected a transposon plasmid encoding for TAZ-4SA (a TAZ isoform that cannot be 
phosphorylated and inhibited by LATS kinases) and obtained a comparable cooperation 
with Capzb deletion (Fig. 5G and Supplementary Fig. 3F). Overall this indicates that 
regulation of YAP/TAZ by actin assembly dynamics regulates YAP in parallel to the Hippo 






Capzb regulates liver homeostasis by controlling tissue mechanics 
Data gathered so far indicate that Capzb regulates cellular forces in vitro, and the activity 
of a key mechanotransduction pathway in vivo. We then sought to test the idea that CAPZ 
regulates tissue mechanical properties also in vivo. For this we monitored F-actin and MLC 
phosphorylation[75] and found them increased in CAPZ LKO liver tissue compared to the 
controls (Fig. 6A). Importantly, this was associated to increased tissue stiffness, which can 
be an indirect readout of actomyosin contractility in cells[76], as measured by atomic force 
microscopy (Fig. 6B). Moreover, target genes that are inhibited in hepatocytes subjected to 
high stiffness[1,53] are downregulated in CAPZ LKO livers (Fig. 6C), further supporting the 
view that CAPZ regulates the cell’s mechanical properties. To functionally validate these 
findings, we inhibited ROCK activity in CAPZ LKO mice, which efficiently reduced MLC 
phosphorylation (Fig. 6D), and scored YAP-dependent phenotypes. As shown in Fig. 6E-
G, hallmark phenotypes induced by Capzb deletion, including expression of direct YAP 
target genes, were inhibited by Fasudil treatment. Altogether, these data indicate a 
function of Capzb in restraining tissue tension, and a physiological role for tissue tension in 







Here we found that inactivation of the capping protein Capzb induced increased cell 
tension and tissue stiffness, and enabled pMLC activity in soft environments which would 
normally suppress it, including the liver[53]. Capzb inactivation induced liver overgrowth, 
hepatocyte dedifferentiation and repatterning of liver metabolism, which all depend on the 
YAP mechanotransduction pathway. These phenotypes were similar in strength, and 
overlapping by gene expression analyses, with published liver mutants of the Hippo 
pathway, and can be readily seen by inactivating Capzb in adult hepatocytes. We also 
found that Capzb and Hippo inactivation cooperate to drive hepatocyte proliferation, 
genetically supporting the view that mechanical signals regulate YAP/TAZ through both 
LATS-dependent[77] and LATS-independent mechanisms[78,79]. This makes CAPZ the 
only genetically-validated YAP/TAZ regulator from flies[80,81] to mammals besides the 
Hippo pathway. We did not find evidence for a mechanical activation of beta-catenin 
though[82], because zonation defects are compatible, if anything, with inhibited beta-
catenin[64]. 
Our results suggest that capping of the F-actin barbed end is crucial to regulate cell 
mechanics in vitro and in vivo, and a required determinant of adult liver homeostasis. The 
phenotypes observed in Capzb-null livers were stable up to 30 weeks (not shown), 
suggesting that the novel function that we describe here for CAPZ cannot be easily 
compensated, and that CAPZ plays a prominent role in regulating cell and tissue 
mechanotransduction. These results now open the interesting possibility that CAPZ levels 
and activity are regulated in tissues, eventually contributing to pattern cell mechanics, 
YAP/TAZ and perhaps other mechanotransduction pathways. The existence of a whole 
family of CAPZ-regulatory proteins and the known but so far poorly addressed role of 
phosphoinositides as regulators of CAPZ[31] represent a possible basis to better 
understand in future how CAPZ activity, and by association F-actin assembly dynamics, 
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Figure 1. The F-actin capping protein Capzb regulates cellular forces in vitro 
(A) Representative pictures of control (WT) and CAPZ KO mouse adult fibroblasts (MAFs) 
plated for 24 hours on microprinted fibronectin-coated islands of the indicated adhesive 
area and stained for YAP/TAZ and EdU incorporation. Quantification of nuclear YAP/TAZ 
on the right. n=2 (>100 cells per condition in total). Scale bar = 10µm. 
(B) Quantification of proliferation in MAFs plated as in A, as assayed by EdU 
incorporation. n=2 (>100 cells per condition in total). 
(C) Representative high-magnification immunofluorescent stainings for F-actin bundles 
(Phalloidin) in the cytoplasm of WT and Capzb-null MAFs. n=3 with consistent results. 
Scale bar = 3µm. 
(D) and (E) FRAP (fluorescence recovery after photobleaching) analysis of WT and 
Capzb-null MAFs transfected with GFP-Actin (D) or mCherry-Vinculin (E), indicated as 
mean and s.e.m. Inset: half-time (t1/2) and 95% Confidence Interval of Actin recovery 
calculated by fitting the data to a monoexponential function. See Supplementary Figure 
1E-F for representative images. n=2 (D: >25 cells per condition in total; E: >40 cells per 
condition in total). Scale bar = 1.5µm. 
(F) and (G) Quantification of the number (F) and size (G) of focal adhesions by TIRF (total 
internal reflection fluorescence) of MAFs transfected with mCherry-Vinculin. See 
Supplementary Figure 1G for representative images. n=2 (16 cells per condition). 
(H) Average F-actin (Phalloidin) and Vinculin immunofluorescence stainings in WT and 
Capzb-null MAFs plated on cross-bow fibronectin-coated micropatterns. 
Immunofluorescence of multiple individual cells on ECM micropatterns were stacked (n=25 
per condition); the resulting image shows the average pixel intensity as a multicolor look-
up table. Scale bar = 5µm. 
(I) Traction force analysis of WT and Capzb-null MAFs plated on stiff (G’=10kPa) 
fibronectin-coated polyacrylamide hydrogels. n=2 (50 cells per condition). Left: 
representative force maps with cell and nucleus contour overlaid. Local force is indicated 
by a multicolor look-up table. Right: box plot (median, quartiles and extremes). n=3 (50 
cells per condition). 
(J) Representative immunofluorescent stainings for pMLC and F-actin bundles (Phalloidin) 
in WT and Capzb-null MAFs plated on soft (G’=1kPa) hydrogels. On the right: 
quantification of cells displaying pMLC staining. n=3 (80 cells per condition). Scale bar = 
3µm. 
(K). Traction force analysis of WT and Capzb-null fibroblasts plated on soft (G’=1kPa) 





Unless otherwise indicated, graphs are average and single points with unpaired two-tailed 
Student’s t-test. Immunostainings were repeated in independent experiments, and a 
representative result is shown. 





Figure 2. Capzb restricts YAP activity, prevents liver overgrowth and maintains 
adult hepatocyte quiescence 
(A) Immunostaining for endogenous CAPZB in liver sections from control (WT) and CAPZ 
LKO mice. Asterisks indicate non-hepatocyte cells that remain positive for CAPZB. 
Occasional patches of non-recombined cells (WT, white dotted line) surrounded by the 
Capzb-null tissue (positive for β-galactosidase) serve as internal control. Scale bar =20µm. 
(B) Expression of established YAP/TAZ target genes, as measured by RNA sequencing of 
whole livers from control and CAPZ LKO mice . Average expression levels in control (WT) 
mice was arbitrarily set equal to 1, and all other data are relative to this. n=4 for each 
genotype. 
(C) Similarity matrix between Capzb liver knockouts, Hippo liver knockouts (Mst1/2 a[78] 
b[28], Sav1/WW45[78], Lats1/2[26]), Yap liver transgenics (Tg a[60] b[18] c[20]), and an 
unrelated liver knockout (outlier[79]). Coefficients were calculated for the indicated 
pairwise comparisons based on genes significantly overexpressed (fold>1.5; P≤0.05). 
(D) Left: representative Immunostaining for YAP in liver sections from control (WT) or 
CAPZ LKO mice. DAPI serves as nuclear counterstain. Scale bar = 10µm. Right: 
quantification of hepatocytes displaying nuclear YAP. n=3 for each genotype. 
(E) Low magnification YAP immunofluorescence in a liver section from a CAPZ LKO 
mouse with occasional non-recombined hepatocytes (WT). n=3 mice were consistent. 
Scale bar = 20µm. 
(F) Representative pictures of control (WT) and CAPZ LKO livers upon dissection. On the 
right: quantification of body/liver weight ratio (see also Supplementary Table 1). n=9 for 
each genotype. 
(G) and (H) Representative stainings for EdU (G, n=3 for each genotype) and phospho-
Histone3 (H, n=2 for each genotype) and their quantifications. Scale bars = 10µm. 
(I) Expression of proliferation marker genes as measured by RNA sequencing of whole 
livers from control and CAPZ LKO mice. Average expression levels in control (WT) mice 
was arbitrarily set equal to 1, and all other data are relative to this. n=4 for each genotype. 
Graphs are average and single points (mice) with unpaired two-tailed Student’s t-test with 
Welch’s correction. Immunostainings were repeated in independent sections of 





Figure 3. Capzb is required to maintain hepatocyte cell differentiation 
(A) Representative hematoxylin and eosin (H&E, left) and immunostainings for the atypical 
ductal cell markers CK19 and A6 (center and right) in control (WT) and CAPZ LKO liver 
sections. Quantification of the CK19-positive area in sections containing the portal area. 
n=3 per genotype. Scale bar = 100µm. 
(B) Expression of liver progenitor/cholangiocyte markers as measured by RNA sequencing 
of whole livers from control and CAPZ LKO mice . Average expression levels in control 
(WT) mice was arbitrarily set equal to 1, and all other data are relative to this. n=4 for each 
genotype. 
(C) Appearance of cells double-positive for differentiated hepatocyte (HNF4α) and atypical 
ductal cell (CK19) markers in CAPZ LKO livers. Scale bar = 5µm. Quantification in 
sections of the portal area. n=3 for each genotype. ** P<0.01. 
(D) Expression of Notch pathway and Notch target genes as measured by RNA 
sequencing of whole livers from control and CAPZ LKO mice . Average expression levels 
in control (WT) mice was arbitrarily set equal to 1, and all other data are relative to this. 
n=4 for each genotype. 
(E) Representative immunostainings for HES1 in control (WT) and CAPZ LKO liver 
sections. HES1 is restricted to bile duct cells (asterisks) in WT mice. Co-localization with 
HNF4α (arrowheads) was only observed in CAPZ LKO mice. Scale bar = 15µm. 
(F) Double immunofluorescence for CK19 and β-galactosidase (used as hepatocyte 
lineage tracer) in CAPZ LKO livers (whole liver KO). Quantification in sections not 
containing the portal area. Scale bar = 30µm. 
(G) Double immunofluorescence for CK19 and β-galactosidase (used as hepatocyte 
lineage tracer) in Capzb-fl/fl; ROSA26-LSL-lacZ mice with live HTV injection of Cre 
transposon plasmid, inducing recombination in single hepatocytes. Scale bar = 15µm. 
Graphs are average and single points (mice) with unpaired two-tailed Student’s t-test with 
Welch’s correction. Immunostainings were repeated in independent sections of 





Figure 4. Capzb controls hepatocyte zonation and liver metabolism 
(A) Expression of pericentral hepatocyte marker genes as measured by RNA sequencing 
of whole livers from control and CAPZ LKO mice . Average expression levels in control 
(WT) mice was arbitrarily set equal to 1, and all other data are relative to this. n=4 for each 
genotype. 
(B) and (C) Immunofluorescence for the pericentral hepatocyte markers GS (glutamine 
synthase - B) and CYP8B1 (C) on liver sections from control (WT) and CAPZ LKO mice, in 
the region of the central vein. Scale bar = 80µm (B), 120µm (C).  
(D) Analysis of cell death by TUNEL staining of pericentral liver sections (left: 
representative stainings; right: quantification) in control (WT) and CAPZ LKO mice 24 
hours after injection with a toxic dose of acetaminophen (APAP). n=2 mice for each 
genotype. Scale bar = 80µm 
(E) Serum alanine aminotransferase (ALT) levels was measured from sera of mice 8 hours 
after APAP injection, as in (D) n=2 mice for each genotype. 
(F) Expression of gluconeogenesis enzymes as measured by RNA sequencing of whole 
livers from control and CAPZ LKO mice . Average expression levels in control (WT) mice 
was arbitrarily set equal to 1, and all other data are relative to this. n=4 for each genotype. 
(G) Glucose tolerance test after intraperitoneal injection in control (WT) and CAPZ LKO 
mice. Statistical significance was calculated on the area under the curve (AUC) values. 
Average and s.e.m. n≥4 mice for each genotype. 
Graphs are average and single points (mice) or s.e.m. with unpaired two-tailed Student’s t-
test with Welch’s correction. Immunostainings were repeated in independent sections of 






Figure 5. Capzb regulates liver homeostasis through YAP1 and in parallel to Hippo 
(A) Liver/body weight ratio of the indicated CAPZ LKO, CAPZ+YAP LKO (n>6 for each 
genotype) and YAP LKO mice (n=3). 
(B) EdU incorporation in the indicated mice. n=3 for each genotype. 
(C) and (D) Representative immunofluorescence for the atypical ductal cell marker CK19 
(C) and for the pericentral marker GS (D) on liver sections from the indicated mice. n=3 
mice were consistent for each staining. Scale bar = 100µm (C), 80µm (D). 
(E) Glucose tolerance test upon intraperitoneal injection as measured by glucose area 
under the curve (AUC) in mice of the indicated genotypes. WT are control mice. 
(F) Quantification of EdU incorporation in control livers (Capzbfl/fl; ROSA26-LSL-lacZ mice 
injected with GFP transposon), in livers with single-cell inactivation of Capzb (CAPZ CRE: 
Capzbfl/fl; ROSA26-LSL-lacZ mice injected with CRE transposon), with single-cell 
inactivation of Lats1/2 (Lats1/2 CAS9: Capzbfl/fl; ROSA26-LSL-lacZ mice injected with 
RFP-Lats1/2-gRNA and CAS9-expressing transposon), or their combination. Hepatocytes 
were transduced by hydrodynamic tail vein injection. n=3 for each genotype. See 
Supplementary Fig. 3E for representative stainings. 
(G) Quantification of EdU incorporation in control and CAPZ LKO livers injected with GFP 
or with TAZ-4SA transposons. Hepatocytes were transduced by hydrodynamic tail vein 
injection. n=2 for each genotype. See Supplementary Fig. 3F for representative stainings. 
Graphs are average and single points (mice) with unpaired two-tailed Student’s t-test with 
Welch’s correction. Immunostainings were repeated in independent sections of 






Figure 6. Capzb regulates liver homeostasis and YAP by modulating hepatocyte 
contractility 
(A) Representative immunofluorescence stainings for phosphorylated myosin-light-chain 
(pMLC), F-actin (Phalloidin) and β-galactosidase (recombined cells) in a CAPZ LKO liver 
section. WT indicates non recombined hepatocytes. n=3 mice were consistent. Scale bar = 
20µm. 
(B) Atomic force microscopy (AFM) analyses were performed on control (WT) and CAPZ 
LKO livers. Left: Representative AFM maps, with squares corresponding to single 
adjacent measurements. Right: Box plot (median, quartiles and extremes). n>4 maps 
from 2 mice of each genotype. 
(C) Expression of hepatocyte mechano-responsive genes as measured by RNA 
sequencing of whole livers from control and CAPZ LKO mice. Average expression levels in 
control (WT) mice was arbitrarily set equal to 1, and all other data are relative to this. n=4 
for each genotype. 
(D) Representative immunofluorescence stainings for phosphorylated myosin-light-chain 
(pMLC) on liver sections of mice of the indicated genotypes treated without or with the 
Fasudil ROCK-inhibitor (ROCKi). n=3 mice were consistent. Scale bar = 80µm. 
(E) Expression of YAP target genes as measured by qPCR of whole livers from control 
(WT) and CAPZ LKO mice without or with Fasudil (ROCKi). Gene levels relative to 
GAPDH. Average expression levels in control mice was arbitrarily set equal to 1, and all 
other data are relative to this. n=4 for CAPZ LKO +/- ROCKi. 
(F) and (G) Quantification of EdU incorporation (F) and CK19-positive atypical ductal cells 
(G) in livers from control (WT) and CAPZ LKO mice treated without or with Fasudil 
(ROCKi). n=4 for CAPZ LKO +/- ROCKi. 
Graphs are average and single points (mice) with unpaired two-tailed Student’s t-test with 
Welch’s correction. Immunostainings were repeated in independent sections of 










● Loss of CAPZ leads to liver overgrowth, hepatocyte reprogramming and metabolic 
defects 
● These phenotypes are due to YAP hyperactivation, and occur in parallel to LATS1/2 
● ROCK inhibition rescues the effects of CAPZ inactivation 
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